Skip to content

"Lipoprotein(a) across coronary plaque phenotypes from high-risk to layered plaque: An OCT analysis from the RELACS registry".

Sep 2026 · Journal of Clinical Lipidology · 0 citations · 35 references
Medicine

TL;DR

Increasing Lp(a) levels were associated with OCT-defined coronary plaque phenotypes related to vulnerability and instability, including high-risk and layered plaques, and given the limited patient-level sample size, these findings should be considered exploratory and hypothesis-generating.

Abstract

Background

Lipoprotein(a) [Lp(a)] is a causal risk factor for coronary artery disease, but its relationship with coronary plaque morphology assessed by optical coherence tomography (OCT) remains incompletely characterized.

Objective

To investigate the association between circulating Lp(a) levels and OCT-defined coronary plaque phenotypes using a comprehensive segment-level approach.

Methods

In this prospective single-center study (RELACS registry; NCT05496790), consecutive patients undergoing intracoronary OCT with available Lp(a) measurements were included. Coronary vessels were divided into 3 mm segments and analyzed for plaque characteristics. Lp(a) was primarily modeled as a continuous variable to assess its association with OCT-defined plaque phenotypes, including high-risk, layered, and fibrous plaques. High-risk plaque was defined as the presence of ≥2 criteria between lipid-rich plaque, thin-cap fibroatheroma (TCFA), and macrophages. Mixed-effects logistic regression models were used to account for within-patient clustering.

Results

A total of 952 coronary segments from 50 patients were analyzed. Increasing Lp(a) levels were significantly associated with multiple features of plaque vulnerability, including TCFA, lipid-rich plaques, macrophages, and microchannels. In the multivariate mixed-effects analysis, higher Lp(a) levels were independently associated with a greater likelihood of high-risk plaque (odds ratios [OR] 1.31, 95% CI 1.16-1.48; P < .001) and layered plaques (OR 1.15, 95% CI 1.02-1.29; P = .024), whereas an inverse association was observed with fibrous plaques (OR 0.84, 95% CI 0.70-1.00; P = .047).

Conclusion

Increasing Lp(a) levels were associated with OCT-defined coronary plaque phenotypes related to vulnerability and instability, including high-risk and layered plaques. Given the limited patient-level sample size, these findings should be considered exploratory and hypothesis-generating.

View source

Similar papers

Review Open access Sep 2026

Association of Elevated Lipoprotein(a) levels with vulnerable plaque features assessed by multimodality coronary imaging in patients with coronary artery disease: A systematic review and Meta-analysis

This meta-analysis suggests that high Lp(a) levels are associated with several imaging-defined high-risk coronary plaque features, with the most robust evidence observed for OCT-derived TCFA and plaque rupture.

Jia-Yu Zhang, Yang Tang, Yu-Yang Cao et al. · 0 citations
Open access Sep 2026

Association between serum lipoprotein(a) levels and aortic vulnerable plaques assessed by non-obstructive general angioscopy

Background and aims Elevated lipoprotein(a) [Lp(a)] levels are recognized as a genetic risk factor for atherosclerotic cardiovascular disease. Previous coronary imaging studies have linked elevated Lp(a) levels to vulnerable coronary plaque characteristics. However, the relationship between elevated Lp(a) levels and vu...

K. Kojima, Yudai Tanaka, Katsunori Fukumoto et al. · 0 citations
Open access Sep 2026

Lipoprotein(a) identifies premature coronary artery disease in patients with low LDL-cholesterol: A large multicenter cohort study.

BACKGROUND Lipoprotein(a) [Lp(a)] is a genetically determined, causal risk factor for atherosclerotic cardiovascular disease. Whether elevated Lp(a) is associated with premature coronary artery disease (pCAD) in young and middle-aged adults with low levels of low-density lipoprotein cholesterol (LDL-C) remains poorly c...

Yahya Bawahab, V. C. Vasile · 0 citations
Open access Aug 2026

Lipidic Plaque Features of Polyvascular Disease in Response to Low-Density Lipoprotein Cholesterol <55 mg/dL: Implication of Circulating Lipoprotein(a) Levels.

BACKGROUND Patients with polyvascular disease (PolyVD) or atherosclerosis in the coronaries and at least 1 additional arterial bed are at increased risk of subsequent clinical cardiovascular events. While lowering low-density lipoprotein cholesterol (LDL-C) is recommended in the secondary prevention settings, whether P...

Aya Katasako-Yabumoto, Yu Kataoka, S. Nicholls et al. · 0 citations
Review Sep 2026

Lipoprotein(a) and subclinical atherosclerosis.

Lp(a) is associated with subclinical atherosclerosis, and imaging for subclinical atherosclerosis is useful for risk-stratifying individuals with elevated Lp(a), and CAC scoring has demonstrated utility for risk stratification among individuals with elevated Lp(a).

Apurva Khedagi, Yu-Si Gong, G. Dharmavaram et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.